journal article·2024-03-13

Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability

Xiujie Zhao, Yan Ma, Jianhao Di, Yanqi Qiao, Jie Yu, Yongmei Yin, Rimo Xi, Meng Meng

ACS Applied Materials & Interfaces· Volume 16· Issue 10
Publisher page

Abstract

Pyroptosis has been reported to improve the antitumor effect by evoking a more intense immune response and a therapeutic effect. For phototherapy, several photosensitizers have been found to initiate pyroptosis. However, the effect of pyroptosis associated with apoptosis in enhancing the antitumor therapy needs sufficient characterization, especially under long-term treatment. As a NIR photosensitizer, heptamethine cyanines have been discovered for anticancer phototherapy for deep tissue penetration and inherent tumor-targeted capability. However, they are not quite stable for long-term performance. To investigate the effect of pyroptosis along with apoptosis on the anticancer immune responses and phototherapy, here, we chemically modulate the cyanine IR780 to regulate hydrophobicity, stability, and intracellular targeting. Two photosensitizers, T780T-TPP and T780T-TPP-C 12, were finally optimized and showed excellent photostability with high photothermal conversion efficiency. Although the cellular uptake of the two molecules was both mediated by OATP transporters, T780T-TPP induced tumor cell death via pyroptosis and apoptosis and accumulated in tumor accumulation, while T780T-TPP-C 12 was prone to accumulate in the liver. Ultimately, via one injection-multiple irradiation treatment protocol, T780T-TPP displayed a significant antitumor effect, even against the growth of large tumors (200 mm 3 ).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Heme Oxygenase-1 and Carbon Monoxide · Ocular Oncology and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China

State Key Laboratory of Southern Medicine Utilization, College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan Province, China

Funding

Natural Science Foundation of Tianjin Municipality · National Natural Science Foundation of China

References (23)

Show source-provided references
1. 10.1038/srep4449710.1038/srep44497 ↗
2. 10.1038/s41423-022-00905-x10.1038/s41423-022-00905-x ↗
3. 10.7150/thno.6703610.7150/thno.67036 ↗
4. 10.1002/adma.20210679710.1002/adma.202106797 ↗
5. 10.1002/anie.20201639910.1002/anie.202016399 ↗
6. 10.1016/j.bioactmat.2022.07.01610.1016/j.bioactmat.2022.07.016 ↗
7. 10.1002/adtp.20180006910.1002/adtp.201800069 ↗
8. 10.1021/acs.jmedchem.0c0225010.1021/acs.jmedchem.0c02250 ↗
9. 10.1016/j.biomaterials.2014.05.07310.1016/j.biomaterials.2014.05.073 ↗
10. 10.1021/ja506520310.1021/ja5065203 ↗
11. 10.1002/smll.20190767710.1002/smll.201907677 ↗
12. 10.1002/anie.20220460410.1002/anie.202204604 ↗
13. 10.1038/s41467-019-08722-z10.1038/s41467-019-08722-z ↗
14. 10.1021/jacs.1c0915510.1021/jacs.1c09155 ↗
15. 10.1016/j.immuni.2023.10.00410.1016/j.immuni.2023.10.004 ↗
16. 10.1002/adma.20190785510.1002/adma.201907855 ↗
17. 10.1002/anie.20220309310.1002/anie.202203093 ↗
18. 10.1039/D3TB00236E10.1039/D3TB00236E ↗
19. 10.1021/jacs.7b0426310.1021/jacs.7b04263 ↗
20. 10.1002/anie.20210674810.1002/anie.202106748 ↗
21. 10.1021/jacs.2c1146610.1021/jacs.2c11466 ↗
22. 10.1021/acs.bioconjchem.8b0070810.1021/acs.bioconjchem.8b00708 ↗
23. 10.3109/1061186X.2013.83276710.3109/1061186X.2013.832767 ↗